The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...

Blockbuster weight loss drug Ozempic could get cheaper by 2027, as it's on the list of medications the government is ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...

Food safety advocates, who had urged the ban for decades, do not anticipate difficulties in the transition and hope this will lead to more bans on synthetic dyes. Also in public health news: baby ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

American scientists found inhaling xenon boosted brain health and improved problem-solving skills, which could potentially ...

And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...

"The results of this study we're talking about are disturbing," said Dr. Ted Huey, Director of Butler Hospitals' memory and ...